Stay updated on Open-Label Surufatinib in EU NET Patients Clinical Trial
Sign up to get notified when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.

Latest updates to the Open-Label Surufatinib in EU NET Patients Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check20 days agoChange DetectedNotice about potential government funding delays was removed. The core study information remains unchanged.SummaryDifference0.3%

- Check41 days agoChange DetectedPosted study results are now visible on the page, and the study record dates have been updated to include Results First Posted 2025-07-25.SummaryDifference0.4%

- Check63 days agoChange DetectedThe page updates to include a government funding lapse notice and a status update about operating conditions, plus a new version label (v3.2.0) while removing the old version (v3.1.0).SummaryDifference3%

- Check70 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

- Check84 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no substantive content changes otherwise.SummaryDifference0.2%

Stay in the know with updates to Open-Label Surufatinib in EU NET Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.